Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.860
-0.140 (-7.00%)
Dec 18, 2025, 2:23 PM EST - Market open
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $3.34 million as of December 18, 2025. Its market cap has increased by 11.10% in one year.
Market Cap
3.34M
Enterprise Value
-2.46M
1-Year Change
11.10%
Ranking
Category
Stock Price
$1.86
Market Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $3.34M, a decrease of -97.86%. That is a compound annual growth rate of -32.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 3.59M | 55.00% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |